Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 8
Submit an article Journal homepage
1,099
Views
13
CrossRef citations to date
0
Altmetric
Review Article

Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia

G. Doreen te RaaDepartment of Hematology;Lymmcare (lymphoma and Myeloma Center Amsterdam)
,
Jitka MalcikovaDepartment of Hematology and Oncology, University Hospital, Brno, Czech Republic
,
Sarka PospisilovaDepartment of Hematology and Oncology, University Hospital, Brno, Czech Republic
,
Martin TrbusekDepartment of Hematology and Oncology, University Hospital, Brno, Czech Republic
,
Mark MrazDepartment of Hematology and Oncology, University Hospital, Brno, Czech Republic
,
Maria Le Garff-TavernierAP-HP, Hopital Pitié-Salpêtrière, Service d’Hématologie Biologique, Paris, France
,
Hélène Merle-BéralAP-HP, Hopital Pitié-Salpêtrière, Service d’Hématologie Biologique, Paris, France
,
Ke LinDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
,
Andrew R. PettittDepartment of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
,
Olaf MerkelLaboratory for Immunological & Molecular Cancer Research, Universitätsklinik Salzburg, Salzburg, Austria;Department of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
,
Tatjana StankovicSchool of Cancer Sciences, University of Birmingham, Birmingham, UK
,
Marinus H. van OersDepartment of Hematology;Lymmcare (lymphoma and Myeloma Center Amsterdam)
,
Eric ElderingLaboratory of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands;Lymmcare (lymphoma and Myeloma Center Amsterdam)
,
Stephan StilgenbauerDepartment of Internal Medicine III, University of Ulm, Ulm, Germany
,
Thorsten ZenzDepartment of Translational Oncology, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ) and Department of Medicine V, University Hospital Heidelberg, Heidelberg, Germany
,
Arnon P. KaterDepartment of Hematology;Lymmcare (lymphoma and Myeloma Center Amsterdam)Correspondence[email protected]
& for the European Research Initiative on CLL (ERIC) show all
Pages 1849-1853 | Received 01 Apr 2013, Accepted 02 Apr 2013, Published online: 24 Jun 2013

References

  • Kay NE, O’Brien SM, Pettitt AR, et al. The role of prognostic factors in assessing “high-risk” subgroups of patients with chronic lymphocytic leukemia. Leukemia 2007;21:1885–1891.
  • Binet JL, Caligaris-Cappio F, Catovsky D, et al. Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia. Blood 2006;107:859–861.
  • Dohner H, Fischer K, Bentz M, et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995;85:1580–1589.
  • Zenz T, Krober A, Scherer K, et al. Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up. Blood 2008;112:3322–3329.
  • Zenz T, Eichhorst B, Busch R, et al. TP53 mutation and survival in chronic lymphocytic leukemia. J Clin Oncol 2010;28:4473–4479.
  • Gonzalez D, Martinez P, Wade R, et al. Mutational status of the TP53 gene as a predictor of response and survival in patients with chronic lymphocytic leukemia: results from the LRF CLL4 trial. J Clin Oncol 2011;29:2223–2229.
  • Austen B, Powell JE, Alvi A, et al. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. Blood 2005;106: 3175–3182.
  • Austen B, Skowronska A, Baker C, et al. Mutation status of the residual ATM allele is an important determinant of the cellular response to chemotherapy and survival in patients with chronic lymphocytic leukemia containing an 11q deletion. J Clin Oncol 2007;25:5448–5457.
  • Skowronska A, Parker A, Ahmed G, et al. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial. J Clin Oncol 2012;30:4524–4532.
  • Pospisilova S, Gonzalez D, Malcikova J, et al. ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia. Leukemia 2012;26:1458–1461.
  • Mraz M, Malinova K, Kotaskova J, et al. miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities. Leukemia 2009;23:1159–1163.
  • Zenz T, Habe S, Denzel T, et al. Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial. Blood 2009;114:2589–2597.
  • Zenz T, Mohr J, Eldering E, et al. miR-34a as part of the resistance network in chronic lymphocytic leukemia. Blood 2009;113: 3801–3808.
  • Asslaber D, Pinon JD, Seyfried I, et al. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Blood 2010;115:4191–4197.
  • Mohr J, Helfrich H, Fuge M, et al. DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing. Blood 2011;117:1622–1632.
  • Eldering E, Spek CA, Aberson HL, et al. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 2003;31:e153.
  • Mous R, Jaspers A, Luijks DM, et al. Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction. Leukemia 2009;23:1352–1355.
  • Lin K, Adamson J, Johnson GG, et al. Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration. Clin Cancer Res 2012;18:4191–4200.
  • Best OG, Gardiner AC, Majid A, et al. A novel functional assay using etoposide plus nutlin-3a detects and distinguishes between ATM and TP53 mutations in CLL. Leukemia 2008;22:1456–1459.
  • Le Garff-Tavernier, Blons H, Nguyen-Khac F, et al. Functional assessment of p53 in chronic lymphocytic leukemia. Blood Cancer J 2011;1:e5.
  • Carter A, Lin K, Sherrington PD, et al. Detection of p53 dysfunction by flow cytometry in chronic lymphocytic leukaemia. Br J Haematol 2004;127:425–428.
  • He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130–1134.
  • Pettitt AR, Sherrington PD, Stewart G, et al. p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 2001;98:814–822.
  • Johnson GG, Sherrington PD, Carter A, et al. A novel type of p53 pathway dysfunction in chronic lymphocytic leukemia resulting from two interacting single nucleotide polymorphisms within the p21 gene. Cancer Res 2009;69:5210–5217.
  • Navrkalova V, Sebejoua L, Zemanova J, et al. Haematologica 2013, april 12 (pm10.2358552H).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.